An Incisive, In-depth Analysis on the Intraosseous Infusion Devices Market
This study offers a comprehensive, 360 degree analysis on the Intraosseous Infusion Devices market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Intraosseous Infusion Devices market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Intraosseous infusion devices are emergency medical products intended for managing life threatening conditions. These products are generally used when there is no access to veins for desired infusion. Intraosseous vascular access is a rapid and alternative method for immediate medical intervention during emergency situations. The global intraosseous infusion devices market is projected to register 2X market growth between 2016 and 2026, witnessing a significant CAGR of 7.2% over the forecast period. The global intraosseous infusion devices market is estimated to be valued at US$ 5,468.5 Mn by the end of 2026.
Growing need for immediate vascular access and rising number of emergency cases expected to boost global market growth
Intraosseous infusion is recommended during peripheral venous access failure for cardiopulmonary resuscitation, which in turn is expected to favour the growth of the global intraosseous infusion devices market over the forecast period. Growth of the global intraosseous infusion devices market is primarily driven by rising concerns of the medical device industry for military medics and air medical emergency services. A rising number of traumatic surgeries in hospital settings and increasing prevalence of cardiovascular disorders is expected to further bolster market growth.
However, a high possibility of compartment syndrome due to gushing of fluids and drugs into soft tissues; limitations in the case of individuals with severe osteoporosis and hypovolemic conditions; and impediment of IO infusion devices after arrival of vein viewer are factors likely to restrict market growth over the forecast period.
Market segmentation
The global intraosseous infusion devices market is segmented on the basis of Product Type (B.I.G (Bone Injection Gun), FAST1, EZ-IO, FAST Responder, Intraosseous Needles, Others); Technology (Manual, Automatic); End User (Emergency Medical Services, Hospitals, Ambulatory Surgical Centres, Cardiac Care Centres); Route of Administration (Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus); and Region (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa).
FAST Responder product type segment is expected to experience significant gain in terms of volume
The FAST Responder segment was valued at US$ 474.5 Mn in 2015 and this is expected to increase to US$ 506.3 Mn by the end of 2016. The EZ-IO segment is expected to be the most attractive segment in terms of incremental opportunity over the forecast period.
Automatic technology segment is likely to register a healthy CAGR in terms of value
The Automatic segment is estimated to account for 52.7% market share by the end of 2026. The Automatic segment is expected to grow 2.1X from 2016 to 2026 with a dominating CAGR. The Manual segment is expected to register a CAGR of 6.4% over the forecast period and create incremental opportunity of US$ 1,111.2 Mn between 2016 and 2026.
The Head of Humerus route of administration segment is projected to witness a significant CAGR over the forecast period
The Head of Humerus segment accounted for 22.0% market share in 2016 and is expected to reach 23.2% market share by 2026 end. The Sternum segment is expected to register a CAGR of 7.4% with incremental opportunity of US$ 810.0 Mn over the forecast period.
Hospitals end user segment is expected to be the most attractive segment in terms of incremental opportunity and CAGR
The Hospitals segment is expected to grow 2.2X from 2016 to 2026 and register a CAGR of 7.7% over the forecast period. The Cardiac Care segment is expected to experience high growth in terms of revenue during the forecast period.
North America is expected to remain the dominant regional market
The North America market is estimated to account for a market share of 25.9% by the end of 2016 and this is likely to increase to 27.2% by 2026, witnessing a CAGR of 7.8% in terms of revenue over the forecast period. The APEJ market was valued at US$ 566.0 Mn in 2015 and is likely to increase to US$ 600.4 Mn by the end of 2016. Western Europe is expected to be the fastest growing market in terms of revenue growth in the global intraosseous infusion devices market, registering a CAGR of 7.6% over the forecast period.
Market players are focussing on new product launches and market growth through capacity expansion
Pyng Medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Co. are some of the companies operating in the global intraosseous infusion devices market. These companies are increasing their distribution network by expanding locally and globally through collaborations and partnerships; and are focussing on increasing market presence by setting up new production facilities in high growth regions such as India and China. There is also a heightened focus on maintaining high standards in product quality and diversifying the product portfolio through structured innovation and strategic investments in R&D initiatives.
The report “Intraosseous Infusion Devices Market: Global Industry Analysis & Opportunity Assessment, 2016–2026” offers a 10-year forecast of the global intraosseous infusion devices market for the period 2016 – 2026. In this comprehensive study, we have focussed on market performance and identified the key factors and trends influencing the market across the different segments and regions of the global intraosseous infusion devices market.
Report description
Our primary objective in creating this report is to offer useful insights, updates, and information related to market opportunities in the global intraosseous infusion devices market. The report begins with an overview of the global intraosseous infusion devices market followed by a detailed analysis of the key market drivers, restraints, trends, value forecasts, and opportunities for players operating in the global intraosseous infusion devices market.
To understand and assess opportunities in this market, we have segmented the global intraosseous infusion devices market on the basis of Product Type, Route of Administration, Technology, End User, and Region. In the subsequent sections, we analyse the global intraosseous infusion devices market in terms of market value and present a detailed market outlook for the various segments and regions, focussing on a micro-level analysis of segmental growth across the different regions.
At the end of the report, we present a detailed analysis of the competitive landscape, taking into account the key market players and their growth strategies – both short-term and long-term. This dashboard view of leading companies operating in the global intraosseous infusion devices market is an effort to help report audiences gauge the current market scenario and the contribution of individual players. Our main objective here is to provide a detailed comparative assessment of key providers specific to the different market segments, to help readers acquire segment-specific manufacturer insights and to identify and evaluate key competitors on the basis of an in-depth assessment of their capabilities and success factors. We have also profiled the leading companies operating in the global intraosseous infusion devices market and presented a detailed analysis of their key product offerings and latest developments. The companies we have featured in the report are:
- Pyng Medical Corp.
- Cook Medical Incorporated
- PerSys Medical
- Aero Healthcare
- Teleflex, Inc.
- Becton Dickinson and Co.
Research methodology
We utilise extensive primary and secondary research to ascertain the overall market size, top industry players, top products, and industry associations. We validate the gathered data using the triangulation method and further scrutinise it using advanced tools to obtain relevant insights. To ascertain the size of the global intraosseous infusion devices market, we have also taken into account the revenue generated by the leading market players. To ensure an accurate forecast, we begin by sizing up the current market, which forms the basis of how the global intraosseous infusion devices market is expected to take shape in the near future. We have analysed the different global intraosseous infusion devices market segments in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identifying key trends likely to impact the global intraosseous infusion devices market. In addition, we have considered the Year-on-Year (Y-o-Y) growth to understand the predictability of the market and to identify growth opportunities for companies operating in the global intraosseous infusion devices market.
Another useful feature of this report is our analysis of the key market segments in terms of absolute dollar opportunity, important for assessing the degree of opportunity that a provider can achieve, as well as to identify potential resources from a sales and delivery perspective in the global intraosseous infusion devices market. To understand key segments in terms of their growth and performance in the global intraosseous infusion devices market, we have also developed a market attractiveness index to help providers identify existing market opportunities.
COVID -19 : Impact Analysis
Request the coronavirus impact analysis across industries and markets
Request Covid -19 ImpactGet in touch
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.